Quadria Capital Closes Oversubscribed US$1 Billion Fund III to Advance Healthcare Transformation Across Asia
New Delhi, Delhi, India: Fund close exceeds initial target despite a challenging fundraising environment, reflecting strong investor confidence in India and Southeast Asia healthcare
Existing investors increased commitment amount by an average of 80%
New capital raised from blue-chip global institutions, alongside a significant rise in Asian investor participation
Quadria Capital, Asia's premier healthcare-focused private equity firm, today announced the final close of its Fund III with US$1.07 billion in total commitments, significantly exceeding its original $800 million target.
The oversubscribed fundraise comprises over US$954 million in primary commitments and US$114 million in committed co-investment capital. An additional US$300 million co-investment capacity is anticipated over the course of the investment phase, bringing total committed capital to approximately US$1.3 billion upon full deployment.
This latest fundraise is around 60% larger than the firm's previous $600m fund raised in 2020, cementing Quadria's position as the largest dedicated healthcare private equity fund in South and Southeast Asia.
'Fund III's close, amid one of the most demanding fundraising climates in recent memory, is a powerful validation of our strategy and our mission,' said Abrar Mir, Co-Founder and Managing Partner, Quadria Capital. 'It reflects deep global investor conviction in the transformational opportunity in Asian Healthcare, where social impact and financial performance go hand in hand.'
Global Institutional Backing Across Continents
At a time when global capital is cautious, Quadria's ability to consistently attract top-tier global investors underscores the strong conviction in its investment strategy and the undeniable opportunities in the Asian healthcare market.
Quadria Capital's largest existing backers include prominent North American and European sovereign wealth funds, asset managers, and strategic corporates. The Fund also secured new commitments from globally recognized institutional investors. Most notably, there was strong backing from leading institutions across the GCC, including Saudi Arabia, the UAE, and Bahrain. The fundraise further attracted interest from India, with fresh capital from major banks, insurance companies, and family offices. Additionally, the Fund received robust re-up commitments from impact investors – underscoring Quadria's continued dedication to scalable, high-impact healthcare businesses that deliver lifesaving care to underserved populations across Asia.
Positioned for Structural Growth in Asia's $5 Trillion Healthcare Market
'With Asia expected to drive 40% of global healthcare growth by 20301, Fund III positions Quadria to lead a new era of private capital-driven healthcare transformation across the region,' Abrar Mir added.
'Asia's healthcare sector is at a pivotal moment, and it will remain in the limelight in 2025, especially with investment interest in India in areas like single-specialty hospitals, diagnostic chains, medical devices, and pharmaceutical manufacturing, which includes APIs and CDMOs. This sector will see growth because of higher healthcare consumption, cost-efficiency initiatives, and deepening technology integration. We are entering a golden decade of healthcare transformation. Our investment philosophy centers on forging deep partnerships with India's healthcare visionaries as the 'partner of choice', providing strategic guidance and operational support to help them scale their businesses and achieve market leadership,' said Dr Amit Varma, Co-Founder and Managing Partner, Quadria Capital.
India As A Core Market for Healthcare Innovation and Investment
Quadria Capital's investment thesis is especially relevant in India, where healthcare transformation is both a national imperative and a private capital opportunity. India is emerging as a strategic manufacturing hub as global pharmaceutical and MedTech supply chains shift towards the country
Per capita healthcare spend in India stands at just $74, significantly below regional peers like Thailand ($364) and Malaysia ($487), with nearly 50% of all healthcare costs paid out-of-pocket
The new fundraise can fuel Indian healthcare innovation by strategically deploying capital in high-growth sectors like specialised care and pharma manufacturing, with a focus on building scalable, affordable solutions for over a billion people.
Fund III will build a diversified portfolio of approximately 10 market-leading companies, taking both significant minority and majority stakes, and further scaling impact through targeted co-investments from Limited Partners (LPs).
Already nearly 40% deployed – including closed and signed investments – the fund has invested in Aragen Life Sciences (a global CRDMO serving over 400 pharma clients), NephroPlus (Asia's largest dialysis chain), and Maxivision (India's leading eye care chain). Two new investments in Southeast Asia are expected soon. Fund III builds on Quadria Capital's track record of successful exits from Funds I and II, underscoring the strength of its investment strategy, operational expertise and ability to distribute capital back to investors.
About Quadria:
Founded in 2012, Quadria Capital is Asia's premier healthcare investor managing over US$4 billion in assets across 27 investments in South and Southeast Asia including India, Vietnam, Indonesia, Malaysia and Singapore. Quadria Capital aims to create significant and sustainable shareholder value by partnering with exceptional healthcare businesses to enhance their impact and scale, while generating superior returns for investors.
For more information, please visit www.quadriacapital.com
1https://www.bcg.com/publications/2025/india-the-unmissable-asia-healthcare-opportunity
View source version on businesswire.com: https://www.businesswire.com/news/home/20250526913375/en/
Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Ekinops completes the acquisition of Olfeo and becomes a network cybersecurity player
PARIS, June 2, 2025 /PRNewswire/ -- EKINOPS (Euronext Paris: FR0011466069) (Euronext Paris: EKI), leading supplier of telecommunications solutions for telecom operators and enterprises, announces the completion of the acquisition of 100% of the share capital of Olfeo, a French provider of SSE (Security Service Edge) cybersecurity software. The transaction, which was subject to customary closing conditions, was announced in a press release on May 15, 2025[1]. This combination creates a leading European player in the network cybersecurity market, in the fast-growing segments of SSE (Security Service Edge) and SASE (Secure Access Service Edge), bringing French expertise to the European and global stage. Final terms of the transaction On 30 May 2025, Ekinops acquired 100% of Olfeo's share capital through its holding company, Oscar SAS, from its founding shareholders, financial investors and employee shareholders. This acquisition was fully financed in cash, using Ekinops' own funds and the syndicated credit line dedicated to external growth, provided by its banking partners. Olfeo's management team is fully committed to this merger. In this context, Alexandre Souillé, founder and CEO of Olfeo, along with his team, will continue to develop the cybersecurity activity within Ekinops. Olfeo is consolidated in Ekinops' accounts from 1 June 2025. Olfeo, a French leader in SSE and enterprise web security Founded in 2003 and based in Paris, Olfeo is a cybersecurity software company that protects enterprise information systems from cyberattacks and risks related to employee Internet usage. Olfeo's web security gateway solutions are offered through a subscription model, either as SaaS (Software as a Service) or on-premises. Olfeo is one of the leading European players in SSE and offers a web security solution that combines multiple layers of security (SWG, CASB, DNS, DLP, etc.)[2] to protect enterprise information systems. With a team of 60 employees, half of whom are dedicated to R&D, Olfeo secures network and web access of over 500 customers and partners (businesses, local authorities, healthcare institutions, French governmental service and infrastructure operators, etc.). Olfeo generated €6.3m in recurring revenue (ARR - Annual Recurring Revenue) in 2024, with an EBITDA[3] margin of over 20%. Ekinops becomes a European market leader in Secure Access Service Edge (SASE) The convergence of network connectivity and cybersecurity challenges is at the heart of today's digital transformation for businesses. Operators are very much on the look for single-vendor network cybersecurity solutions that are sovereign, immediately available, and combining performance, security, ease of deployment and regulatory compliance. The SASE for networks cybersecurity market is estimated at over $9bn by 2025, with an average annual growth rate of +13% over the next few years[4]. By 2026, Ekinops aims to position itself in the "Unified SASE" segment, with a fully integrated solution specifically designed for mid-sized companies (SMB and SME). Ekinops intends to address this segment by leveraging its installed customer base with major telecom operators. The "Unified SASE" market is estimated to exceed $600m by 2025, with an average annual growth rate of over +27% over the next few years. Together, Ekinops and Olfeo will be able to meet the growing needs of public and private organizations for secure cloud access and agile network infrastructures, offering a high-performing and responsible European technology. For more information, refer to the press release dated 15 May 2025:Ekinops announces the acquisition of Olfeo, a cybersecurity software provider for businesses EKINOPS ContactDidier Brédy, Chairman and CEOcontact@ Omnes, Investor relationTel.: +33 (0)1 53 67 36 92momnes@ Dugast, Press relationTel.: +33 (0)1 53 67 36 74adugast@ [1] Press release dated 15 May 2025: Ekinops announces the acquisition of Olfeo, a cybersecurity software provider for businesses[2] SWG: Secure Web GatewayCASB: Cloud Access Security BrokerDNS: Domain Name SystemDLP: Data Loss Prevention[3] EBITDA (Earnings before interest, taxes, depreciation, and amortization) corresponds to current operating income restated for (i) amortization, depreciation and provisions and (ii) income and expenses linked to share-based payments.[4] Source: Dell'Oro Group Photo: View original content to download multimedia: SOURCE Ekinops
Bloomberg
19 minutes ago
- Bloomberg
South Africa Farm Exports Surge 10% as US Shipments Climb
South African agricultural exports rose 10% in the first quarter to $3.36 billion from a year earlier as port performance improved and shipments to the US climbed, an industry body said. The 14% increase in trade to the US, which totaled $202 million, comes as South Africa braces for the imposition of a 30% tariff on exports to the country by the Trump administration when a 90-day grace period expires in July.
Yahoo
24 minutes ago
- Yahoo
Indian man arrested with venomous vipers in bag at Mumbai airport
Authorities in India have arrested a man for trying to smuggle dozens of rare reptiles, including poisonous snakes, into the country. The Indian citizen, who was returning from Thailand, was stopped by customs officials at the airport in Mumbai city on Sunday. Officials said the reptiles, including 44 venomous vipers, were found concealed in the man's checked-in luggage. The reptiles have been seized under various wildlife protection laws in India. The passenger has not been named and as he is in custody. He has not commented on his arrest. Customs officials have released photographs on X of colourful snakes squirming in a dish. In their post, they said they had seized three spider-tailed horned vipers, five Asian leaf turtles and 44 Indonesian pit vipers from the passenger. It isn't clear where the reptiles had been sourced from. Leopard cub found in passenger's luggage at Indian airport Rare Madagascar tortoises seized at Mumbai airport While it is not illegal to import animals into the country, India's wildlife protection law bans the import of certain species, including those classified as endangered or protected by the government. A passenger also needs to get the required permits and licenses before importing any wildlife. Reports of customs officials seizing banned wildlife from passengers trying to smuggle them into the country are not uncommon. In January, Indian authorities arrested a Canadian man at the Delhi airport for carrying a crocodile skull in his luggage and month later, officials at the Mumbai airport stopped a passenger carrying five Siamang gibbons, a small ape native to the forests of Indonesia, Malaysia and Thailand. The gibbons, listed as endangered by the International Union for Conservation of Nature, were concealed in a plastic crate placed inside the passenger's trolley bag. In November, customs officers arrested two passengers returning from Bangkok for carrying12 exotic turtles. In 2019, officials at the Chennai airport seized a horned pit viper snake, five Iguanas, four blue-tongued skinks, three green tree frogs and 22 Egyptian tortoises from a man travelling from Thailand. Follow BBC News India on Instagram, YouTube, Twitter and Facebook.
